Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 291552011000036114 | gliclazide 30 mg modified release tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 291554011000036117 | gliclazide 30 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| gliclazide 30 mg modified release tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| gliclazide 30 mg modified release tablet | Is a | gliclazide | true | Inferred relationship | Some | ||
| gliclazide 30 mg modified release tablet | has intended active ingredient | gliclazide | true | Inferred relationship | Some | 1852554226 | |
| gliclazide 30 mg modified release tablet | has Australian BoSS | gliclazide | true | Inferred relationship | Some | 1852554226 | |
| gliclazide 30 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| gliclazide 30 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 1852554227 |
Reference Sets
Medicinal product unit of use reference set
FHIR